Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein
- PMID: 2017172
- PMCID: PMC360036
- DOI: 10.1128/mcb.11.5.2665-2674.1991
Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein
Abstract
Evi-1 was originally identified as a common site of viral integration in murine myeloid tumors. Evi-1 encodes a 120-kDa polypeptide containing 10 zinc finger motifs located in two domains 380 amino acids apart and an acidic domain located carboxy terminal to the second set of zinc fingers. These features suggest that Evi-1 is a site-specific DNA-binding protein involved in the regulation of RNA transcription. We have purified Evi-1 protein from E. coli and have employed a gel shift-polymerase chain reaction method using random oligonucleotides to identify a high-affinity binding site for Evi-1. The consensus sequence for this binding site is TGACAAGATAA. Evi-1 protein specifically protects this motif from DNase I digestion. By searching the nucleotide sequence data bases, we have found this binding site both in sequences 5' to genes in putative or known regulatory regions and within intron sequences.
Similar articles
-
The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.Oncogene. 1995 Jul 6;11(1):191-8. Oncogene. 1995. PMID: 7624127
-
Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.Mol Cell Biol. 1993 Jul;13(7):4291-300. doi: 10.1128/mcb.13.7.4291-4300.1993. Mol Cell Biol. 1993. PMID: 8321231 Free PMC article.
-
The ZNF35 human zinc finger gene encodes a sequence-specific DNA-binding protein.FEBS Lett. 1993 Apr 26;321(2-3):233-6. doi: 10.1016/0014-5793(93)80115-b. FEBS Lett. 1993. PMID: 8477855
-
The EVI-1 gene--its role in pathogenesis of human leukemias.Leuk Res. 2000 Jul;24(7):553-8. doi: 10.1016/s0145-2126(00)00031-x. Leuk Res. 2000. PMID: 10867128 Review.
-
The transcription factor Evi-1.Int J Biochem Cell Biol. 1999 Dec;31(12):1367-71. doi: 10.1016/s1357-2725(99)00064-3. Int J Biochem Cell Biol. 1999. PMID: 10641791 Review.
Cited by
-
EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.J Biol Chem. 2016 Jun 24;291(26):13591-607. doi: 10.1074/jbc.M115.708156. Epub 2016 Apr 21. J Biol Chem. 2016. PMID: 27129260 Free PMC article.
-
EVI1 in Leukemia and Solid Tumors.Cancers (Basel). 2020 Sep 18;12(9):2667. doi: 10.3390/cancers12092667. Cancers (Basel). 2020. PMID: 32962037 Free PMC article. Review.
-
EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.Blood. 2012 Jun 14;119(24):5838-49. doi: 10.1182/blood-2011-11-393827. Epub 2012 May 2. Blood. 2012. PMID: 22553314 Free PMC article.
-
Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.EMBO J. 1994 Feb 1;13(3):504-10. doi: 10.1002/j.1460-2075.1994.tb06288.x. EMBO J. 1994. PMID: 8313895 Free PMC article.
-
Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6454-8. doi: 10.1073/pnas.90.14.6454. Proc Natl Acad Sci U S A. 1993. PMID: 8341654 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources